Tumor cells with <i>KRAS</i> or <i>BRAF</i> mutations or <i>ERK5/MAPK7</i> amplification are not addicted to ERK5 activity for cell proliferationLochhead, Pamela A.; Clark, Jonathan; Wang, Lan-Zhen; Gilmour, Lesley; Squires, Matthew; Gilley, Rebecca; Foxton, Caroline; Newell, David R.; Wedge, Stephen R.; Cook, Simon J. · Cell Cycle · 2016